Read More

SeaStar Medical Announces The Publication Of A Peer-Reviewed Article In ‘Nature Scientific Reports’ Describes The Mechanism Of Action Of The Co’s Selective Cytopheretic Device In The Immunomodulation Of Excessive Inflammation

SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces the publication of a

ICU